Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

European Union Approves Oxis Turbuhaler (Formoterol) for Paediatric Asthma LONDON, ENGLAND -- January 3, 2002 -- AstraZeneca announced today that Oxis® Turbuhaler® (formoterol) has been granted approval for maintenance treatment of asthma in children (six years and older) in 14 European Union (EU) states* through the Mutual Recognition Procedure (MRP). Oxis Turbuhaler is an effective beta 2-agonist with a fast onset of bronchodilation (within one-three minutes) and a long duration of action (more than 12 hours). It is used to relieve broncho-obstructive symptoms and should be taken in addition to inhaled corticosteroids. Oxis has been shown to improve lung function and asthma symptoms in children not adequately controlled on inhaled corticosteroids alone. The rapid onset of action means that patients experience an immediate symptom relief. "With the approval of Oxis Turbuhaler for use in children we are very pleased to be able to provide paediatricians and GPs with the new effective treatment option. Oxis not only improves the quality of life of the children, but also that of the parents," said Dr. Colin Reddrop, AstraZeneca Vice-President and Head of Respiratory and Inflammation Research and Development (R&D). * Sweden, Denmark, Finland, Germany, Austria, Netherlands, Spain, Italy, Portugal, United Kingdom, Ireland, Greece, Belgium, Luxemburg SOURCE: AstraZeneca E-mail this page to a friend or colleague! To print, use this version